ck2-dependent phosphorylation of progesterone receptors (PR) on ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells

Molecular and Cellular Biology

Volumn 31, Issue 12, 2011, Pages 2439-2452

  Hagan, Christy R ^a   Regan, Tarah M ^a   Dressing, Gwen E ^a   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; CASEIN KINASE II; GESTAGEN; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN BIRC3; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; BREAST NEOPLASMS; CASEIN KINASE II; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE; SERINE; TRANSCRIPTION, GENETIC;

EID: 79956122926     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01246-10     Document Type: Article

References (81)

1. Anderson, G. L., et al. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712.
2. Arcuri, F., et al. 2000. Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 72:239-247.
3. Bagowski, C. P., J. W. Myers, and J. E. Ferrell. 2001. The classical progesterone receptor associates with p42 MAPK and is involved in PI3-K signaling in Xenopus oocytes. J. Biol. Chem. 276:37708-37714.
4. Beerli, R. R., and N. E. Hynes. 1996. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271:6071-6076.
5. Beral, V. 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427.
6. Blind, R. D., and M. J. Garabedian. 2008. Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 109:150-157.
7. Boonyaratanakornkit, V., et al. 2001. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8:269-280.
8. Brisken, C., et al. 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. U. S. A. 95:5076-5081.
9. Bush, I. E., S. A. Hunter, and R. A. Meigs. 1968. Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparations of liver. Biochem. J. 107:239-258.
10. Carvajal, A., et al. 2005. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75. Breast Cancer Res. Treat. 94:171-183.
11. Channavajhala, P., and D. C. Seldin. 2002. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene 21:5280-5288.
12. Chlebowski, R. T., et al. 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 289:3243-3253.
13. Chlebowski, R. T., et al. 2009. Breast cancer after use of estrogen plus progestin in postmenopausal women. N. Engl. J. Med. 360:573-587.
14. Cicatiello, L., et al. 2004. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol. Cell. Biol. 24:7260-7274.
15. Clemm, D. L., et al. 2000. Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine sitespecific monoclonal antibody. Mol. Endocrinol. 14:52-65.
16. Daniel, A. R., E. J. Faivre, and C. A. Lange. 2007. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol. Endocrinol. 21:2890-2906.
17. Daniel, A. R., et al. 2010. The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. Mol. Endocrinol. 24:2126-2138.
18. Daniel, A. R., T. P. Knutson, and C. A. Lange. 2009. Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Mol. Cell Endocrinol. 308:47-52.
19. Daniel, A. R., and C. A. Lange. 2009. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 106:14287-14292.
20. Daniel, A. R., et al. 2007. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:188-201.
21. Darnel, A. D., T. K. Archer, and K. Yang. 1999. Regulation of 11betahydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line. J. Steroid Biochem. Mol. Biol. 70:203-210.
22. Dressing, G. E., and C. A. Lange. 2009. Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell proliferation. Steroids 74:573-576.
23. Duncan, J. S., et al. 2008. An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets. Mol. Cell. Proteomics 7:1077-1088.
24. Faivre, E. J., A. R. Daniel, C. J. Hillard, and C. A. Lange. 2008. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol. Endocrinol. 22:823-837.
25. Faivre, E. J., and C. A. Lange. 2007. Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Srcdependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol. Cell. Biol. 27:466-480.
26. Faust, M., and M. Montenarh. 2000. Subcellular localization of protein kinase CK2. A key to its function? Cell Tissue Res. 301:329-340.
27. Filhol, O., and C. Cochet. 2009. Protein kinase CK2 in health and disease: cellular functions of protein kinase CK2: a dynamic affair. Cell. Mol. Life Sci. 66:1830-1839.
28. Foster, F. M., et al. 2009. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer. Breast Cancer Res. 11:R41.
29. Gregory, C. W., et al. 2004. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J. Biol. Chem. 279: 7119-7130.
30. Groshong, S. D., et al. 1997. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol. Endocrinol. 11:1593-1607.
31. Guerra, B., and O. G. Issinger. 2008. Protein kinase CK2 in human diseases. Curr. Med. Chem. 15:1870-1886.
32. Guo, C., A. T. Davis, S. Yu, S. Tawfic, and K. Ahmed. 1999. Role of protein kinase CK2 in phosphorylation nucleosomal proteins in relation to transcriptional activity. Mol. Cell. Biochem. 191:135-142.
33. Guo, C., S. Yu, A. T. Davis, and K. Ahmed. 1999. Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells. Cancer Res. 59: 1146-1151.
34. Horwitz, K. B., Y. Koseki, and W. L. McGuire. 1978. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103:1742-1751.
35. Horwitz, K. B., M. B. Mockus, and B. A. Lessey. 1982. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell 28:633-642.
36. Hundertmark, S., H. Buhler, M. Rudolf, H. K. Weitzel, and V. Ragosch. 1997. Inhibition of 11 beta-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J. Endocrinol. 155:171-180.
37. Joshi, P. A., H. W. Jackson, A. G. Beristain, M. A. Di Grappa, P. A. Mote, C. L. Clarke, J. Stingl, P. D. Waterhouse, and R. Khokha. 2010. Progesterone induces adult mammary stem cell expansion. Nature 465:803-807.
38. Kato, S., et al. 2005. Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1. J. Clin. Endocrinol. Metab. 90:1181-1188.
39. Kelliher, M. A., D. C. Seldin, and P. Leder. 1996. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 15: 5160-5166.
40. Koyama, K., K. Myles, R. Smith, and Z. Krozowski. 2001. Expression of the 11beta-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells. J. Steroid Biochem. Mol. Biol. 76:153-159.
41. Landesman-Bollag, E., P. L. Channavajhala, R. D. Cardiff, and D. C. Seldin. 1998. p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene 16:2965- 2974.
42. Landesman-Bollag, E., et al. 2001. Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol. Cell. Biochem. 227:153-165.
43. Lange, C. A., T. Shen, and K. B. Horwitz. 2000. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc. Natl. Acad. Sci. U. S. A. 97:1032-1037.
44. Liston, P., et al. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-353.
45. Lupien, M., and M. Brown. 2009. Cistromics of hormone-dependent cancer. Endocr. Relat. Cancer 16:381-389.
46. Lydon, J. P., et al. 1995. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:2266-2278.
47. Lydon, J. P., G. Ge, F. S. Kittrell, D. Medina, and B. W. O'Malley. 1999. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59:4276-4284.
48. Madak-Erdogan, Z., M. Lupien, F. Stossi, M. Brown, and B. S. Katzenellenbogen. 2011. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol. Cell. Biol. 31:226-236.
49. Meggio, F., and L. A. Pinna. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17:349-368.
50. Migliaccio, A., et al. 1998. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17: 2008-2018.
51. Miro, F. A., et al. 2002. Persistent nuclear accumulation of protein kinase CK2 during the G1-phase of the cell cycle does not depend on the ERK1/2 pathway but requires active protein synthesis. Arch. Biochem. Biophys. 406: 165-172.
52. Miyata, Y. 2009. Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery. Cell. Mol. Life Sci. 66:1840-1849.
53. Mote, P. A., S. Bartow, N. Tran, and C. L. Clarke. 2002. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res. Treat. 72:163-172.
54. Mulac-Jericevic, B., J. P. Lydon, F. J. DeMayo, and O. M. Conneely. 2003. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U. S. A. 100:9744-9749.
55. Murphy, L. C., L. J. Murphy, and R. P. Shiu. 1988. Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells. Biochem. Biophys. Res. Commun. 150:192-196.
56. Musgrove, E. A., C. S. Lee, and R. L. Sutherland. 1991. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes. Mol. Cell. Biol. 11:5032-5043.
57. Narayanan, R., A. A. Adigun, D. P. Edwards, and N. L. Weigel. 2005. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol. Cell. Biol. 25:264-277.
58. Nardulli, A. M., and B. S. Katzenellenbogen. 1988. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 122:1532-1540.
59. Olsten, M. E., and D. W. Litchfield. 2004. Order or chaos? An evaluation of the regulation of protein kinase CK2. Biochem. Cell Biol. 82:681-693.
60. Osborne, C. K., R. Schiff, G. Arpino, A. S. Lee, and V. G. Hilsenbeck. 2005. Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. Breast 14:458-465.
61. Owen, G. I., J. K. Richer, L. Tung, G. Takimoto, and K. B. Horwitz. 1998. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273:10696- 10701.
62. Pierson-Mullany, L. K., and C. A. Lange. 2004. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol. Cell. Biol. 24:10542-10557.
63. Resing, K. A., et al. 1995. Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry 34:2610-2620.
64. Richer, J. K., et al. 2002. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:5209- 5218.
65. Rothe, M., M. G. Pan, W. J. Henzel, T. M. Ayres, and D. V. Goeddel. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252.
66. Sartorius, C. A., et al. 1994. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors; only antiprogestinoccupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res. 54:3868-3877.
67. Seagroves, T. N., J. P. Lydon, R. C. Hovey, B. K. Vonderhaar, and J. M. Rosen. 2000. C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol. Endocrinol. 14:359-368.
68. Shen, T., K. B. Horwitz, and C. A. Lange. 2001. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent downregulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol. Cell. Biol. 21:6122-6131.
69. Steeg, P. S., and Q. Zhou. 1998. Cyclins and breast cancer. Breast Cancer Res. Treat. 52:17-28.
70. Stoecklin, E., M. Wissler, D. Schaetzle, E. Pfitzner, and B. Groner. 1999. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. J. Steroid Biochem. Mol. Biol. 69:195-204.
71. Takimoto, G. S., et al. 1996. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J. Biol. Chem. 271:13308-13316.
72. Tawfic, S., et al. 2001. Protein kinase CK2 signal in neoplasia. Histol. Histopathol. 16:573-582.
73. Trembley, J. H., Z. Chen, G. Unger, J. Slaton, B. T. Kren, C. Van Waes, and K. Ahmed. 2010. Emergence of protein kinase CK2 as a key target in cancer therapy. Biofactors 36:187-195.
74. Trembley, J. H., G. Wang, G. Unger, J. Slaton, and K. Ahmed. 2009. Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell. Mol. Life Sci. 66:1858-1867.
75. Ward, R. D., and N. L. Weigel. 2009. Steroid receptor phosphorylation: assigning function to site-specific phosphorylation. Biofactors 35:528-536.
76. Weigel, N. L., et al. 1995. Phosphorylation and progesterone receptor function. J. Steroid Biochem. Mol. Biol. 53:509-514.
77. Wilson, G. R., et al. 2006. Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br. J. Cancer 95:1410-1414.
78. Yu, I. J., D. L. Spector, Y. S. Bae, and D. R. Marshak. 1991. Immunocytochemical localization of casein kinase II during interphase and mitosis. J. Cell Biol. 114:1217-1232.
79. Zhang, Y., et al. 1997. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol. Endocrinol. 11:823-832.
80. Zhang, Y., C. A. Beck, A. Poletti, D. P. Edwards, and N. L. Weigel. 1994. Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. J. Biol. Chem. 269:31034-31040.
81. Zhang, Z., C. Funk, D. Roy, S. Glasser, and J. Mulholland. 1994. Heparinbinding epidermal growth factor-like growth factor is differentially regulated by progesterone and estradiol in rat uterine epithelial and stromal cells. Endocrinology 134:1089-1094.